ALANA YOUNG: Open Payments
NPI 1326423328 · RANDOLPH, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$424 in 23 payments from 12 companies in 2025. Trend: 2023 $1,070 · 2024 $1,048 · 2025 $424
Food & beverage: $425
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $78 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $51 |
| PFIZER INC. | 3 | $48 |
| Astellas Pharma US Inc | 2 | $44 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $37 |
| Otsuka America Pharmaceutical, Inc. | 2 | $30 |
| AstraZeneca Pharmaceuticals LP | 2 | $29 |
| Exact Sciences Corporation | 1 | $29 |
| Lilly USA, LLC | 1 | $21 |
| Axsome Therapeutics, Inc. | 1 | $19 |
Products named: TRINTELLIX, Veozah, CAPLYTA, Ozempic, PREVNAR 20, REXULTI, Cologuard Collection Kit, MOUNJARO.
Industry payments across NJ — which companies pay providers there.
